Letters, Testimony & Filings State Medical Boards Should Oppose AI-Enabled Prescription Renewal Systems July 30, 2026
Letters, Testimony & Filings Testimony Before the Food and Drug Administration’s Pharmacy Compounding Advisory Committee (PCAC) Regarding Emideltide Free Base and Emideltide Acetate July 24, 2026
Letters, Testimony & Filings Testimony Before the Food and Drug Administration’s Pharmacy Compounding Advisory Committee Regarding Placing MOTS-c on the 503A Bulks List: No Human Studies or Proven Benefits, But Possible Risks July 23, 2026
Letters, Testimony & Filings Testimony Before the Food and Drug Administration’s Pharmacy Compounding Advisory Committee About BPC-157 (Free Base) and BPC-157 (Acetate) July 23, 2026
Letters, Testimony & Filings Public Citizen Petitions the FDA to Ban Direct-To-Consumer Advertising of Human Prescription Drugs July 23, 2026
Letters, Testimony & Filings Public Citizen Testimonies Before the Food and Drug Administration’s Pharmacy Compounding Advisory Committee Regarding BPC-157, MOTS-c, and Emideltide July 23, 2026